Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Scilex Announces Nationwide Stocking And Launch Of GLOPERBA, FDA-Approved Treatment For Gout Flares In Adults

Author: Benzinga Newsdesk | June 10, 2024 11:51am
Stocking of GLOPERBA is underway in all of the wholesalers with which Scilex has stocking arrangements throughout the U.S and Scilex expects completion of stocking by Wednesday June 12, 2024.Today, Scilex is launching
  • Stocking of GLOPERBA is underway in all of the wholesalers with which Scilex has stocking arrangements throughout the U.S and Scilex expects completion of stocking by Wednesday June 12, 2024.
  • Today, Scilex is launching its third commercial product, GLOPERBA
  • Patients will have support of the co-pay savings card for GLOPERBA
  • GLOPERBA is the first and only liquid oral formulation of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
  • Scilex increased production of GLOPERBA and product availability under the brand marketed and distributed by Scilex Pharmaceuticals, Inc. for GLOPERBA

Posted In: SCLX